Researchers develop promising drug delivery method that could replace injections with pills Dr. Kamal Kant Kohli9 Jan 2023 7:30 PM ISTFor some chronic conditions such as rheumatoid arthritis, treatment often involves lifelong injections. New delivery strategies that combine efficacy...
Mirikizumab efficacy to placebo for treating moderate-to-severe plaque psoriasis Medha Baranwal3 Jan 2023 8:00 PM ISTUSA: Interleukin (IL)-23 and IL-17 are known to play critical roles in the development of psoriatic disease, so therapies targeting these cytokines...
Palmoplantar Plaque Psoriasis associated with Diabetes, Hypertension, Obesity, and Metabolic Syndrome- IDOJ Study Dr Manoj Kumar Nayak2 Jan 2023 9:45 AM ISTPalmoplantar Plaque Psoriasis associated with Diabetes, Hypertension, Obesity, and Metabolic Syndrome- IDOJ Study Psoriasis is a T cell‑mediated...
Secukinumab Dose Tapering ensures increased effectiveness of plaque psoriasis treatment Dr. Kamal Kant Kohli21 Oct 2022 7:30 PM ISTCHINA: According to a research study published in the journal Dermatologic Therapy, tapering off secukinumab dosages for individuals with plaque...
Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan Ruchika Sharma17 Oct 2022 2:30 PM ISTDenosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
Tildrakizumab therapy proves beneficial for Plaque Psoriasis Dr. Kamal Kant Kohli3 Oct 2022 8:00 PM ISTITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published...
Roflumilast cream effective for treating plaque psoriasis: JAMA Dr. Kamal Kant Kohli26 Sept 2022 7:30 PM ISTUSA: According to a study published in JAMA Network, roflumilast cream was effective in treating plaque psoriasis in patients after 8 weeks of...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Bristol Myers Squibb bags USFDA approval for plaque psoriasis oral treatment Sotyktu Ruchika Sharma12 Sept 2022 1:29 PM ISTPsoriasis is a widely prevalent, chronic, systemic immune-mediated disease.
Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA Ruchika Sharma19 Jun 2022 11:30 AM ISTUpon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...
FDA Approves tapinarof cream- first nonsteroidal treatment for plaque psoriasis Dr. Kamal Kant Kohli26 May 2022 10:00 AM ISTThe Food and Drugs Administration has approved Vtama cream for treating plaque psoriasis with varying severity. The approval was announced by...
Ixekizumab safe to use in Pediatric Patients with Moderate to Severe Plaque Psoriasis: JAMA Medical Dialogues Editorial Team30 April 2022 9:00 AM ISTA new study conducted by Amy S. Paller and team showed improvements in patient-reported outcomes and objective measures of full psoriasis skin...
